Apriem Advisors’s Apollo Endosurgery, Inc. APEN Stock Holding History

Apriem Advisors’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-26	Closed	–	–	587
2017 Q1	$0	Hold	26	–	–	﹤0.01%	741
2016 Q4	$0	Hold	26	–	–	﹤0.01%	751
2016 Q3	$0	Hold	26	–	–	﹤0.01%	655
2016 Q2	$0	Hold	26	–	–	﹤0.01%	656
2016 Q1	$0	Buy	+26	New	+$361	﹤0.01%	631

Other funds holding APEN

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RWA

Ropes Wealth Advisors Boston, Massachusetts $515M AUM 21.76% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Apriem Advisors's APEN Position: Q2 2017 in Review

Apriem Advisors sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2017, closing a stake of 26 shares.

Apriem Advisors first reported a position in APEN in Q1 2016 and held it in 5 quarters. The position peaked at $0 in Q1 2017. 7 funds tracked by Wall St. Rank hold APEN as of Q2 2017.

Apriem Advisors reported no remaining Apollo Endosurgery, Inc. position as of Q2 2017 after selling out during the quarter.
Apriem Advisors sold 26 Apollo Endosurgery, Inc. shares in Q2 2017.
Apriem Advisors first reported a position in Apollo Endosurgery, Inc. in Q1 2016 and held it in 5 quarters.
Apriem Advisors's Apollo Endosurgery, Inc. position peaked at $0 in Q1 2017.
7 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2017.

Based on Apriem Advisors's 13F filing for Q2 2017, filed 4 Aug 2017.